Ziprasidone hydrochloride monohydrate

Cat. No.: OB0225LY-0151

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR.

Size:

INQUIRY Datasheet MSDS

Product Overview

Description: Ziprasidone hydrochloride monohydrate is an atypical antipsychotic drug that works primarily by inhibiting the reuptake of dopamine and 5-hydroxytryptophan.

Synonym: CP 88059; 138982-67-9; Ziprasidone HCl hydrate; 5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride hydrate; 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, hydrochloride, hydrate (1:1:1); 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone monohydrochloride, monohydrate; 2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monohydrochloride, monohydrate

CAS No.: 138982-67-9

Compound CID: 60853

Formula: C₂₁H₂₁ClN₄OS·HCl·H₂O

Formula Weight: 467.12

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Ziprasidone hydrochloride monohydrate plays an important role in the field of mood disorders.

Library Information

Targets: Histamine receptor family; 5-HT receptor family; Adrenergic receptor family; Dopamine receptor family; Monoamine transporter

Receptors: 5-HT transporter; 5-HT1A; 5-HT1B; 5-HT1D; 5-HT2A; 5-HT2C; 5-HT6; 5-HT7; D1; D2; D3; H1 receptor; Norepinephrine transporter (NET); α1A-Adrenergic receptor; α2A-Adrenergic receptor

Pathways: GPCR/G protein; Immunology/Inflammation; Neuronal signaling

Plate Number: AOCL-2

Plate Location: h4

Empty Location: a1-h1; a12-h12

Container: 96-well plate

Formulation: 10 mM DMSO

DMSO Max Solubility: 1 mg/mL

Related Products

Inquiry